To observe the acute toxicity of recombinant porcine interferen-alpha （IFN-alpha） in mice and thus provide a basis for the clinical safety. [Method] According to the principles of acute toxicity, all the mice were d...To observe the acute toxicity of recombinant porcine interferen-alpha （IFN-alpha） in mice and thus provide a basis for the clinical safety. [Method] According to the principles of acute toxicity, all the mice were divided into two major groups （intraperitoneally injected group and intramuscularly injected group） respectively at high dose, moderate dose and low dose. And the normal control group was also set up. Within 14 d after administration, the behavior of mouse and the degree of toxicity were continuously observed. The hematological indexes and biochemical indexes of blood were detected to obtain the preliminary toxicity data of the recombinant porcine IFN-alpha. And at the end of the experiment, mice were sacrificed for autopsy. [ Result] There was not significant difference in external performance, behavioral characteristics, body temperature, weight, pathological anatomy of visceral organs, hematological indexes and biochemical indexes between the experimental groups and the control group. [ Conclusion] The highest dose of porcine interferon （5.0 x 10s IU per mouse） in this experiment or the dose lower than this dosage should not have significant toxic effects on mice, and the recombinant porcine IFN-alpha is safe in clinical application.展开更多
[ Objective] To study the purification of recombinant porcine interferon-alpha （rPolFN-alpha） and lay a foundation for researches on the structure of the rPolFN-alpha and the preparation of standard proteins. [ Meth...[ Objective] To study the purification of recombinant porcine interferon-alpha （rPolFN-alpha） and lay a foundation for researches on the structure of the rPolFN-alpha and the preparation of standard proteins. [ Method] The rPolFN-alpha were induced and extracted from the recombi- nant E. coil BL21, and they were purified by two strategies. The first strategy was that the rPolFN-alpha were purified by GST （ glutathione S transferase） affinity chromatography, DEAE （diethylaminoethyl） anion exchange chromatography and gel filtration in turn defined as three-step chromatography method; the second strategy was that the rPolFN-alpha were purified by GST affinity chromatography and gel filtration in tum defined as two-step chromatography method. Then the purified products were detected by the SDS-PAGE （sodium dodecyl sulfate polyacrylamide gel electrophoresis） and were identified by western-blotting. [Result] The purity quotient of pudfied products of the two-step chromatography method was 96.0% and that of the three-step chromatography method was 98.8%. The purified products were detected by the SDS-PAGE and the western- blotting, respectively. The results showed that the target band was 45.0 kDa and the specific band was found. [ Conclusion] The purity quotient of proteins of the two-step chromatography method is close to that of the three-step chromatography method, thus the two-step chromatography meth- od is more convenient and more suitable for pilot production than the three-step chromatography method.展开更多
【目的】构建能够稳定表达猪α-干扰素(IFN-α)成熟蛋白的重组干酪乳酸杆菌(Lactobacillus casei CECT5276),为将其作为口服疫苗来提高动物机体免疫力奠定基础。【方法】从质粒pMD18-IFN-α扩增出猪IFN-α成熟蛋白基因,再将其定向克隆...【目的】构建能够稳定表达猪α-干扰素(IFN-α)成熟蛋白的重组干酪乳酸杆菌(Lactobacillus casei CECT5276),为将其作为口服疫苗来提高动物机体免疫力奠定基础。【方法】从质粒pMD18-IFN-α扩增出猪IFN-α成熟蛋白基因,再将其定向克隆到干酪乳酸杆菌整合型表达载体pMJ67的lac启动子下游,得到重组质粒pMJ67-IFN-α,电穿孔转化干酪乳酸杆菌。抽提干酪乳酸杆菌基因组DNA,进行PCR扩增及测序鉴定。采用半定量RTPCR检测猪IFN-αmRNA在干酪乳酸杆菌中的转录水平;采用Western blot对重组干酪乳酸杆菌菌体进行分析,检测其表达产物的活性;用双抗体夹心ELISA法确定最适的乳糖诱导质量浓度。【结果】PCR扩增获得了501bp的IFN-α,成功构建了重组质粒pMJ67-IFN-α,转化干酪乳酸杆菌后获得了重组乳酸杆菌。半定量RT-PCR结果显示,IFN-αmRNA在诱导16h时表达水平最高;Western blot分析表明,构建的重组干酪乳酸杆菌成功表达出了相对分子质量约19ku的重组蛋白,其可与鼠抗猪IFN-α抗体发生特异性反应。ELISA结果表明,当乳糖诱导质量浓度达到8g/L时,猪IFN-α成熟蛋白的表达量达到最大,为1.3μg/L。【结论】将猪IFN-α成熟蛋白基因整合到干酪乳酸杆菌基因组中,构建的重组乳酸杆菌能够稳定表达猪IFN-α成熟蛋白。展开更多
基金Supported by Major Program of Natural Science Foundation of AnhuiProvince ( KJ2008A085)Anhui Key Technology R&D Program( 08010302179)~~
文摘To observe the acute toxicity of recombinant porcine interferen-alpha （IFN-alpha） in mice and thus provide a basis for the clinical safety. [Method] According to the principles of acute toxicity, all the mice were divided into two major groups （intraperitoneally injected group and intramuscularly injected group） respectively at high dose, moderate dose and low dose. And the normal control group was also set up. Within 14 d after administration, the behavior of mouse and the degree of toxicity were continuously observed. The hematological indexes and biochemical indexes of blood were detected to obtain the preliminary toxicity data of the recombinant porcine IFN-alpha. And at the end of the experiment, mice were sacrificed for autopsy. [ Result] There was not significant difference in external performance, behavioral characteristics, body temperature, weight, pathological anatomy of visceral organs, hematological indexes and biochemical indexes between the experimental groups and the control group. [ Conclusion] The highest dose of porcine interferon （5.0 x 10s IU per mouse） in this experiment or the dose lower than this dosage should not have significant toxic effects on mice, and the recombinant porcine IFN-alpha is safe in clinical application.
基金supported by the Key Projects of Natural Science Fund of Anhui Province in 2008 (KJ2008A085)
文摘[ Objective] To study the purification of recombinant porcine interferon-alpha （rPolFN-alpha） and lay a foundation for researches on the structure of the rPolFN-alpha and the preparation of standard proteins. [ Method] The rPolFN-alpha were induced and extracted from the recombi- nant E. coil BL21, and they were purified by two strategies. The first strategy was that the rPolFN-alpha were purified by GST （ glutathione S transferase） affinity chromatography, DEAE （diethylaminoethyl） anion exchange chromatography and gel filtration in turn defined as three-step chromatography method; the second strategy was that the rPolFN-alpha were purified by GST affinity chromatography and gel filtration in tum defined as two-step chromatography method. Then the purified products were detected by the SDS-PAGE （sodium dodecyl sulfate polyacrylamide gel electrophoresis） and were identified by western-blotting. [Result] The purity quotient of pudfied products of the two-step chromatography method was 96.0% and that of the three-step chromatography method was 98.8%. The purified products were detected by the SDS-PAGE and the western- blotting, respectively. The results showed that the target band was 45.0 kDa and the specific band was found. [ Conclusion] The purity quotient of proteins of the two-step chromatography method is close to that of the three-step chromatography method, thus the two-step chromatography meth- od is more convenient and more suitable for pilot production than the three-step chromatography method.
文摘【目的】构建能够稳定表达猪α-干扰素(IFN-α)成熟蛋白的重组干酪乳酸杆菌(Lactobacillus casei CECT5276),为将其作为口服疫苗来提高动物机体免疫力奠定基础。【方法】从质粒pMD18-IFN-α扩增出猪IFN-α成熟蛋白基因,再将其定向克隆到干酪乳酸杆菌整合型表达载体pMJ67的lac启动子下游,得到重组质粒pMJ67-IFN-α,电穿孔转化干酪乳酸杆菌。抽提干酪乳酸杆菌基因组DNA,进行PCR扩增及测序鉴定。采用半定量RTPCR检测猪IFN-αmRNA在干酪乳酸杆菌中的转录水平;采用Western blot对重组干酪乳酸杆菌菌体进行分析,检测其表达产物的活性;用双抗体夹心ELISA法确定最适的乳糖诱导质量浓度。【结果】PCR扩增获得了501bp的IFN-α,成功构建了重组质粒pMJ67-IFN-α,转化干酪乳酸杆菌后获得了重组乳酸杆菌。半定量RT-PCR结果显示,IFN-αmRNA在诱导16h时表达水平最高;Western blot分析表明,构建的重组干酪乳酸杆菌成功表达出了相对分子质量约19ku的重组蛋白,其可与鼠抗猪IFN-α抗体发生特异性反应。ELISA结果表明,当乳糖诱导质量浓度达到8g/L时,猪IFN-α成熟蛋白的表达量达到最大,为1.3μg/L。【结论】将猪IFN-α成熟蛋白基因整合到干酪乳酸杆菌基因组中,构建的重组乳酸杆菌能够稳定表达猪IFN-α成熟蛋白。
